Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage

NCT07053852 is registered in ClinicalTrials.gov with Sherrif Ibrahim as lead sponsor.

NCT NCT07053852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07053852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage
Lead sponsor
Sherrif Ibrahim
Phase
Phase 1
Overall status
Completed
Start date
June 27, 2025
Completion date
December 29, 2025
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratoses, photodamage